Literature DB >> 1599524

Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies.

M E Luchi1, R A Asherson, R G Lahita.   

Abstract

OBJECTIVE: We report an unusual case of primary pulmonary hypertension and review the pertinent literature.
METHODS: A 25-year-old Caucasian woman presented with progressive dyspnea and was found to have pulmonary hypertension. Antiphospholipid antibodies were present. The patient had a prolonged hospital course, was unresponsive to therapy, and died suddenly.
RESULTS: Postmortem examination revealed a large thrombus affecting the right main pulmonary artery, with plexogenic arteriopathy bilaterally.
CONCLUSION: This appears to be the first reported case of primary pulmonary hypertension complicated by thrombosis of a main pulmonary artery in association with antiphospholipid antibodies.

Entities:  

Mesh:

Year:  1992        PMID: 1599524     DOI: 10.1002/art.1780350616

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Pulmonary hypertension, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

2.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Takaono; K Iwasaki; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 4.  The lung in the antiphospholipid syndrome.

Authors:  G Espinosa; R Cervera; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 5.  Pulmonary hypertension in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

Review 6.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

7.  Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis.

Authors:  Mehmet Sayarlioglu; Nazan Topcu; Mustafa Harman; Unal Guntekin; Reha Erkoc
Journal:  Rheumatol Int       Date:  2004-09-18       Impact factor: 2.631

Review 9.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.